Medtronic Resolute Drug-Eluting Stent (DES) Receives Expanded Indication for Treatment of Chronic Total Occlusion (CTO) - Cath Lab Digest https://t.co/uYRxUXjT4p
— Discovery Institute (@discoverynj) February 27, 2019
from Twitter https://twitter.com/discoverynj
February 26, 2019 at 10:02PM
No comments:
Post a Comment